Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Asieris, Astellas, Basilea, Beigene, Eusa, Shenzhen China Resources Gosun, Lianbio, Novavax, Senhwa, Sorrento.